miR-31 reduces cell growth of papillary thyroid carcinoma by RNA-binding protein HuR

Clinical Laboratory

Volumn 61, Issue 11, 2015, Pages 1625-1634

  Wu, Danping ^a   Wang, Bo ^a   Shang, Jiangfeng ^a   Song, Jia ^a   Zhang, Hongdan ^a  

^a the First Affiliated Hospital of Soochow University   (China)

Author keywords

HuR; MiR 31; Papillary thyroid carcinoma

Indexed keywords

CYCLIN B1; CYCLIN D1; MICRORNA 31; PROTEIN BCL 2; PROTEIN P21; PROTEIN P27; RNA BINDING PROTEIN; RNA BINDING PROTEIN HUR; UNCLASSIFIED DRUG; ELAV LIKE PROTEIN 1; ELAVL1 PROTEIN, HUMAN; MICRORNA; MIRN31 MICRORNA, HUMAN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; OVARY CARCINOMA; PATHOGENESIS; SPHEROID CELL; THYROID CARCINOMA; THYROID GLAND TISSUE; UPREGULATION; CARCINOMA; GENETICS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; THYROID TUMOR; TUMOR CELL LINE;

APOPTOSIS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; ELAV-LIKE PROTEIN 1; HUMANS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; THYROID NEOPLASMS;

EID: 84954604181     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2015.150404     Document Type: Article

References (25)

1. Gonzalez-Gonzalez R., Bologna-Molina R, Carreon-Burciaga RG, et al. Papillary thyroid carcinoma: differential diagnosis and prognostic values of its different variants: review of the literature. ISRN Oncol 2011; 2011:915925.
2. Rottiers V, Naar AM MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol 2012; 13:239-50.
3. Huang C, Cai Z, Huang M., et al. miR-219-5p modulates cell growth of papillary thyroid carcinoma by targeting estrogen receptor a. J Clin Endocrinol Metab 2015; 100:E204-13.
4. Wang C, Lu S, Jiang J., et al. Hsa-microRNA-101 suppresses migration and invasion by targeting Racl in thyroid cancer cells. Oncol Lett 2014; 8:1815-21.
5. Kim HS, Lee KS, Bae H.J., et al. MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer. Oncotarget 2015; 10; 6(10):8089-102.
6. Ning Z, Zhu H, Li F., et al. Tumor suppression bymiR-31 in esophageal carcinoma is p21-dependent. Genes Cancer 2014; 5: 436-44.
7. Abdelmohsen K, Kim MM, Srikantan S, et al miR-519 suppresses tumor growth by reducing HuR levels. Cell Cycle 2010; 9: 1354-9.
8. Sahlberg AS, Ruuska M, Granfors K., Penttinen MA. Altered Regulation of ELAVLl/HuR in HLA-B27-Expressing U937 Monocytic Cells. PLoS One 2013; 8:e70377.
9. Fan XC, Steitz JA HNS, a nuclear-cytoplasmic shuttling sequence in HuR. Proc Natl Acad Sci USA 1998; 95:15293-8.
10. Gorospe M. HuR in the mammalian genotoxic response: posttranscriptional multitasking. Cell Cycle 2003; 2:412-4.
11. Abdelmohsen K, Kuwano Y, Kim H.H., Gorospe M. Posttranscriptional gene regulation by RNA-binding proteins during oxidative stress: implications for cellular senescence. Biol Chem 2008; 389: 243-55.
12. Lai A, Kawai T, Yang X., et al. Antiapoptotic function of RNA-binding protein HuR effected through prothymosin alpha. EMBO J 2005; 24:1852-62.
13. Wang W, Caldwell MC, Lin S, Furneaux H., Gorospe M. HuR regulates cyclin A and cyclin Bl mRNA stability during cell proliferation. EMBO J 2000; 19:2340-50.
14. Lloyd RV, Buehler D, Khanafshar E. Papillary thyroid carcinoma variants. Head Neck Pathol 2011; 5:51-6.
15. Silver CE, Owen RP, Rodrigo J.P., et al. Aggressive variants of papillary thyroid carcinoma. Head Neck 2011; 33:1052-9.
16. Floor SL, Hebrant A, Pita J.M., et al. MiRNA expression may account for chronic but not for acute regulation of mRNA expression in human thyroid tumor models. PLoS One 2014; 9:e111581.
17. O'Day E., Lal A. MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res 2010; 12:201.
18. Kouri FM, Hurley LA, Daniel W.L., et al. miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma. Genes Dev 2015; 29:732-45.
19. Li D, Jian W, Wei C., et al. Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer. Int J Clin Exp Pathol 2014; 7:7672-8.
20. Xiong Y, Zhang L, Kebebew E. MiR-20a is upregulated in anaplastic thyroid cancer and targets LIMK1. PLoS One 2014; 9:e96103.
21. Abdelmohsen K, Kuwano Y, Kim H.H., Gorospe M. Posttranscriptional gene regulation by RNA-binding proteins during oxidative stress: implications for cellular senescence. Biol Chem 2008; 389: 243-55.
22. Palanisamy V, Jakymiw A, Van Tubergen EA, D'Silva NJ, Kirkwood KL. Control of cytokine mRNA expression by RNA-binding proteins and microRNAs. J Dent Res 2012; 91:651-8.
23. Bhattacharyya SN, Habermacher R, Martine U., Closs EI, Filipowicz W. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 2006; 125:1111-24.
24. Tominaga K, Srikantan S, Lee E.K., et al. Competitive regulation of nucleolin expression by HuR and miR-494. Mol Cell Biol 2011; 31:4219-31.
25. Abdelmohsen K, Srikantan S, Kuwano Y., Gorospe M. miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels. Proc Natl Acad Sci USA 2008; 105:20297-302.